MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
These awards are given to the top-performing Medline distribution centers [...]
“We are dedicated to partnering with our customers on their [...]
Choosing the right foundation for medium skin tones is really [...]
A handbag plays a quiet but powerful role in shaping [...]
Staying away from smokers matters because secondhand smoke harms the [...]
A fitness gym that invests in a full recovery and [...]
CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology [...]
The company is expected to finalize the Clinical Study Report [...]
Findings published in Nature uncover a microbiome-driven pathway that turns [...]